Skip to main content
. 2019 Aug 19;19:57. doi: 10.1186/s40644-019-0241-5

Fig. 7.

Fig. 7

PSMA-PET (a) in a patient with prostate cancer shows a focus of high uptake intracranially (arrow). The post-contrast MRI (b), however, demonstrates much more widespread intracranial metastatic disease (arrowheads)